300869 康泰医学
已收盘 12-20 15:00:00
资讯
新帖
简况
康泰医学(300869.SZ)与北京超思就专利权纠纷案件签署《和解协议》
智通财经 · 12-12
康泰医学(300869.SZ)与北京超思就专利权纠纷案件签署《和解协议》
康泰医学最新公告:与北京超思就专利权纠纷案件达成和解
证券之星 · 12-12
康泰医学最新公告:与北京超思就专利权纠纷案件达成和解
11月28日康泰医学发布公告,其股东减持377.76万股
证券之星 · 11-28
11月28日康泰医学发布公告,其股东减持377.76万股
康泰医学(300869.SZ)部分股东、董监高完成减持1.43%股份
智通财经网 · 11-28
康泰医学(300869.SZ)部分股东、董监高完成减持1.43%股份
康泰医学:11月26日高管杨志山、寇国治、高瑞斌减持股份合计3000股
证券之星 · 11-27
康泰医学:11月26日高管杨志山、寇国治、高瑞斌减持股份合计3000股
康泰医学获得外观设计专利授权:“注射泵”
证券之星 · 11-27
康泰医学获得外观设计专利授权:“注射泵”
康泰医学新注册《康泰CMS1700B彩色多普勒超声诊断系统FPGA固件软件V1.0.1》项目的软件著作权
证券之星 · 11-26
康泰医学新注册《康泰CMS1700B彩色多普勒超声诊断系统FPGA固件软件V1.0.1》项目的软件著作权
康泰医学:11月19日高管杨志山、寇国治、高瑞斌减持股份合计34.28万股
证券之星 · 11-20
康泰医学:11月19日高管杨志山、寇国治、高瑞斌减持股份合计34.28万股
康泰医学:11月15日高管杨志山、寇国治、高瑞斌减持股份合计34.58万股
证券之星 · 11-18
康泰医学:11月15日高管杨志山、寇国治、高瑞斌减持股份合计34.58万股
康泰医学:11月14日高管杨志山、郑敏、寇国治、刘振红、许云龙、高瑞斌减持股份合计67.58万股
证券之星 · 11-15
康泰医学:11月14日高管杨志山、郑敏、寇国治、刘振红、许云龙、高瑞斌减持股份合计67.58万股
康泰医学:11月13日高管杨志山、郑敏、寇国治、刘振红、许云龙、高瑞斌减持股份合计67.58万股
证券之星 · 11-14
康泰医学:11月13日高管杨志山、郑敏、寇国治、刘振红、许云龙、高瑞斌减持股份合计67.58万股
11月14日康泰医学发布公告,其股东减持22.24万股
证券之星 · 11-14
11月14日康泰医学发布公告,其股东减持22.24万股
康泰医学(300869.SZ)股东王桂丽累计减持415.55万股
智通财经 · 11-14
康泰医学(300869.SZ)股东王桂丽累计减持415.55万股
康泰医学(300869.SZ)获得两项医疗器械注册证
智通财经 · 11-05
康泰医学(300869.SZ)获得两项医疗器械注册证
康泰医学(300869)2024年三季报简析:净利润减94.92%,盈利能力上升
证券之星 · 10-29
康泰医学(300869)2024年三季报简析:净利润减94.92%,盈利能力上升
康泰医学(300869)9月30日股东户数3.5万户,较上期减少1.46%
证券之星 · 10-27
康泰医学(300869)9月30日股东户数3.5万户,较上期减少1.46%
康泰医学(300869.SZ)发布前三季度业绩,净利润990.29万元,同比下降94.92%
智通财经 · 10-27
康泰医学(300869.SZ)发布前三季度业绩,净利润990.29万元,同比下降94.92%
图解康泰医学三季报:第三季度单季净利润同比减85.81%
证券之星 · 10-27
图解康泰医学三季报:第三季度单季净利润同比减85.81%
康泰医学最新公告:股东拟减持不超过1.7145%
证券之星 · 10-22
康泰医学最新公告:股东拟减持不超过1.7145%
康泰医学(300869.SZ)多位股东拟合计减持不超688.9万股
智通财经 · 10-22
康泰医学(300869.SZ)多位股东拟合计减持不超688.9万股
加载更多
公司概况
公司名称:
康泰医学系统(秦皇岛)股份有限公司
所属行业:
专用设备制造业
上市日期:
2020-08-24
主营业务:
康泰医学系统(秦皇岛)股份有限公司的主营业务是医疗诊断、监护设备的研发、生产和销售。产品涵盖血氧类、心电类、超声类、监护类、血压类等多个大类,建立了完善的研发、生产和销售体系。2023年4月,公司Remoltar远程专业彩色多普勒超声诊断系统荣获德国IF设计奖和意大利A设计奖。2023年10月,公司的儿童红外体温计产品斩获2023年广交会设计创新奖银奖,呼吸训练器、动态心电监护仪两款产品斩获铜奖。
发行价格:
10.16
{"stockData":{"symbol":"300869","market":"SZ","secType":"STK","nameCN":"康泰医学","latestPrice":15.39,"timestamp":1734678198000,"preClose":15.37,"halted":0,"volume":2528700,"delay":0,"floatShares":252000000,"shares":401999999,"eps":-0.0485,"marketStatus":"已收盘","marketStatusCode":5,"change":0.02,"latestTime":"12-20 15:00:00","open":15.37,"high":15.56,"low":15.34,"amount":39061300,"amplitude":0.0143,"askPrice":15.4,"askSize":16,"bidPrice":15.39,"bidSize":169,"shortable":0,"etf":0,"ttmEps":-0.0485,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1734917400000},"adr":0,"adjPreClose":15.37,"symbolType":"stock","openAndCloseTimeList":[[1734658200000,1734665400000],[1734670800000,1734678000000]],"highLimit":16.91,"lowLimit":13.83,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":401802977,"pbRate":3.24,"roa":"--","roe":"0.5%","epsLYR":0.41,"committee":0.301053,"marketValue":6184000000,"floatMarketCap":3872000000,"peRate":-317.319578,"changeRate":0.0013,"turnoverRate":0.0101,"status":0},"requestUrl":"/m/hq/s/300869","defaultTab":"news","newsList":[{"id":"2490801174","title":"康泰医学(300869.SZ)与北京超思就专利权纠纷案件签署《和解协议》","url":"https://stock-news.laohu8.com/highlight/detail?id=2490801174","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490801174?lang=zh_cn&edition=full","pubTime":"2024-12-12 19:38","pubTimestamp":1734003507,"startTime":"0","endTime":"0","summary":"2019年10月,本案在法官主持下召开了调解会议,但由于双方的和解主张相差甚大,双方未能达成任何和解协议。2024年5月22日美国专利商标局给出单方再审的第一次审查意见,判定超思专利6个权利要求全部无效。2024年10月23日,美国专利商标局发文认定北京超思的308专利6项权利有效。北京时间2024年12月10日,公司及美国康泰与北京超思达成了和解并签署了《和解协议》。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1224191.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300869","BK0251"],"gpt_icon":0},{"id":"2490801828","title":"康泰医学最新公告:与北京超思就专利权纠纷案件达成和解","url":"https://stock-news.laohu8.com/highlight/detail?id=2490801828","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490801828?lang=zh_cn&edition=full","pubTime":"2024-12-12 19:30","pubTimestamp":1734003027,"startTime":"0","endTime":"0","summary":"康泰医学公告,公司及全资子公司美国康泰与北京超思就专利权纠纷案件达成和解,并签署了《和解协议》。根据协议,康泰同意向北京超思支付100万美元赔偿金,以全面解决和了结涉及被控侵权康泰血氧仪的诉讼。康泰已停止并将继续避免在美国境内制造、进口、使用、提供销售或销售被控侵权康泰血氧仪。公司表示,本案涉诉专利权不涉及公司的核心专利、技术及产品,本次和解结果不会对公司生产经营产生不利影响。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121200032306.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300869","BK0251"],"gpt_icon":0},{"id":"2486396834","title":"11月28日康泰医学发布公告,其股东减持377.76万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2486396834","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486396834?lang=zh_cn&edition=full","pubTime":"2024-11-28 18:01","pubTimestamp":1732788068,"startTime":"0","endTime":"0","summary":"证券之星消息,11月28日康泰医学发布公告《康泰医学:关于持股5%以上股东、部分董事、监事及高级管理人员减持计划实施完毕的公告》,其股东王桂丽于2024年11月14日至2024年11月28日间合计减持377.76万股,占公司目前总股本的0.9402%,变动期间该股股价下跌8.88%,截止11月28日收盘报15.39元。股东增减持详情见下表:根据康泰医学2024年三季报公布的十大股东详情如下:以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112800029674.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300869","BK0251"],"gpt_icon":0},{"id":"2486406360","title":"康泰医学(300869.SZ)部分股东、董监高完成减持1.43%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2486406360","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486406360?lang=zh_cn&edition=full","pubTime":"2024-11-28 17:11","pubTimestamp":1732785070,"startTime":"0","endTime":"0","summary":"智通财经APP讯,康泰医学(300869.SZ)公告,公司持股5%以上股东王桂丽、董事兼高级管理人员杨志山、监事高瑞斌及高级管理人员寇国治合计减持公司股份572万股,占总股本比例1.43%,本次减持股份计划已实施完毕。更多港股重磅资讯,下载智通财经app更多港股及海外理财资讯,请点击www.zhitongcaijing.com(搜索“智通财经”);欲加入智通港股投资群,请加智通客服微信(ztcjkf)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1217263.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["300869","BK0251"],"gpt_icon":0},{"id":"2486582924","title":"康泰医学:11月26日高管杨志山、寇国治、高瑞斌减持股份合计3000股","url":"https://stock-news.laohu8.com/highlight/detail?id=2486582924","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486582924?lang=zh_cn&edition=full","pubTime":"2024-11-27 21:01","pubTimestamp":1732712481,"startTime":"0","endTime":"0","summary":"证券之星消息,根据11月27日市场公开信息、上市公司公告及交易所披露数据整理,康泰医学最新董监高及相关人员股份变动情况:2024年11月26日公司董事,高管杨志山、高管寇国治、监事高瑞斌共减持公司股份3000.0股,占公司总股本为0.0006%。变动期间公司股价下跌0.84%,11月26日当日收盘报15.29元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112700037128.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300869"],"gpt_icon":0},{"id":"2486827018","title":"康泰医学获得外观设计专利授权:“注射泵”","url":"https://stock-news.laohu8.com/highlight/detail?id=2486827018","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486827018?lang=zh_cn&edition=full","pubTime":"2024-11-27 02:10","pubTimestamp":1732644645,"startTime":"0","endTime":"0","summary":"证券之星消息,根据天眼查APP数据显示康泰医学新获得一项外观设计专利授权,专利名为“注射泵”,专利申请号为CN202430189318.3,授权日为2024年11月26日。今年以来康泰医学新获得专利授权57个,较去年同期减少了46.73%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112700003007.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300869"],"gpt_icon":0},{"id":"2486800030","title":"康泰医学新注册《康泰CMS1700B彩色多普勒超声诊断系统FPGA固件软件V1.0.1》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2486800030","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486800030?lang=zh_cn&edition=full","pubTime":"2024-11-26 01:10","pubTimestamp":1732554609,"startTime":"0","endTime":"0","summary":"证券之星消息,近日康泰医学(300869)新注册了《康泰CMS1700B彩色多普勒超声诊断系统FPGA固件软件V1.0.1》项目的软件著作权。今年以来康泰医学新注册软件著作权12个,较去年同期增加了100%。结合公司2024年中报财务数据,今年上半年公司在研发方面投入了5605.5万元,同比增8.85%。数据来源:企查查以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112600000778.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300869","BK0251"],"gpt_icon":0},{"id":"2484156331","title":"康泰医学:11月19日高管杨志山、寇国治、高瑞斌减持股份合计34.28万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2484156331","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484156331?lang=zh_cn&edition=full","pubTime":"2024-11-20 21:01","pubTimestamp":1732107678,"startTime":"0","endTime":"0","summary":"证券之星消息,根据11月20日市场公开信息、上市公司公告及交易所披露数据整理,康泰医学最新董监高及相关人员股份变动情况:2024年11月19日公司董事,高管杨志山、高管寇国治、监事高瑞斌共减持公司股份34.28万股,占公司总股本为0.0853%。变动期间公司股价上涨2.1%,11月19日当日收盘报15.59元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112000037430.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300869"],"gpt_icon":0},{"id":"2484627340","title":"康泰医学:11月15日高管杨志山、寇国治、高瑞斌减持股份合计34.58万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2484627340","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484627340?lang=zh_cn&edition=full","pubTime":"2024-11-18 21:14","pubTimestamp":1731935674,"startTime":"0","endTime":"0","summary":"证券之星消息,根据11月18日市场公开信息、上市公司公告及交易所披露数据整理,康泰医学最新董监高及相关人员股份变动情况:2024年11月15日公司董事,高管杨志山、高管寇国治、监事高瑞斌共减持公司股份34.58万股,占公司总股本为0.0861%。变动期间公司股价下跌3.03%,11月15日当日收盘报15.7元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111800031216.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300869"],"gpt_icon":0},{"id":"2483983371","title":"康泰医学:11月14日高管杨志山、郑敏、寇国治、刘振红、许云龙、高瑞斌减持股份合计67.58万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2483983371","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483983371?lang=zh_cn&edition=full","pubTime":"2024-11-15 21:55","pubTimestamp":1731678956,"startTime":"0","endTime":"0","summary":"证券之星消息,根据11月15日市场公开信息、上市公司公告及交易所披露数据整理,康泰医学最新董监高及相关人员股份变动情况:2024年11月14日公司董事,高管杨志山、董秘,董事,高管郑敏、高管寇国治、高管刘振红、高管许云龙、监事高瑞斌共减持公司股份67.58万股,占公司总股本为0.1682%。变动期间公司股价下跌4.14%,11月14日当日收盘报16.19元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111500045093.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300869"],"gpt_icon":0},{"id":"2483877106","title":"康泰医学:11月13日高管杨志山、郑敏、寇国治、刘振红、许云龙、高瑞斌减持股份合计67.58万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2483877106","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483877106?lang=zh_cn&edition=full","pubTime":"2024-11-14 21:01","pubTimestamp":1731589291,"startTime":"0","endTime":"0","summary":"证券之星消息,根据11月14日市场公开信息、上市公司公告及交易所披露数据整理,康泰医学最新董监高及相关人员股份变动情况:2024年11月13日公司董事,高管杨志山、董秘,董事,高管郑敏、高管寇国治、高管刘振红、高管许云龙、监事高瑞斌共减持公司股份67.58万股,占公司总股本为0.1682%。变动期间公司股价下跌2.09%,11月13日当日收盘报16.89元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111400035653.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300869"],"gpt_icon":0},{"id":"2483876260","title":"11月14日康泰医学发布公告,其股东减持22.24万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2483876260","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483876260?lang=zh_cn&edition=full","pubTime":"2024-11-14 20:01","pubTimestamp":1731585665,"startTime":"0","endTime":"0","summary":"证券之星消息,11月14日康泰医学发布公告《康泰医学:关于持股5%以上股东减持公司股份超过1%的公告》,其股东王桂丽于2024年11月13日合计减持22.24万股,占公司目前总股本的0.0554%,变动期间该股股价下跌2.09%,截止11月13日收盘报16.89元。股东增减持详情见下表:根据康泰医学2024年中报公布的十大股东详情如下:以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111400033593.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300869","BK0251"],"gpt_icon":0},{"id":"2483820895","title":"康泰医学(300869.SZ)股东王桂丽累计减持415.55万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2483820895","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483820895?lang=zh_cn&edition=full","pubTime":"2024-11-14 18:59","pubTimestamp":1731581957,"startTime":"0","endTime":"0","summary":"智通财经APP讯,康泰医学(300869.SZ)公告,公司股东王桂丽累计减持公司股份415.5456万股,减持股份比例已达到公司目前总股本的1.0342%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1211062.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300869","BK0251"],"gpt_icon":0},{"id":"2481152625","title":"康泰医学(300869.SZ)获得两项医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2481152625","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481152625?lang=zh_cn&edition=full","pubTime":"2024-11-05 16:48","pubTimestamp":1730796521,"startTime":"0","endTime":"0","summary":"智通财经APP讯,康泰医学(300869.SZ)发布公告,公司于近日取得了由河北省药品监督管理局颁发的两项《中华人民共和国医疗器械注册证》,分别为:心电图机、臂式电子血压计。以上产品医疗器械注册证的取得,有利于丰富公司产品线,进一步提高公司的核心竞争力,对公司发展具有正面影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1206870.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09996","BK1583","300869","BK1100","159883","BK0251","BK1222","BK1574","09997"],"gpt_icon":0},{"id":"2479546992","title":"康泰医学(300869)2024年三季报简析:净利润减94.92%,盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2479546992","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479546992?lang=zh_cn&edition=full","pubTime":"2024-10-29 06:10","pubTimestamp":1730153418,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期康泰医学发布2024年三季报。截至本报告期末,公司营业总收入3.34亿元,同比下降45.91%,归母净利润990.29万元,同比下降94.92%。本报告期康泰医学盈利能力上升,毛利率同比增幅41.18%,净利率同比增幅15.29%。然而去年的净利率为22.19%,算上全部成本后,公司产品或服务的附加值高。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102900005699.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300869"],"gpt_icon":0},{"id":"2478158795","title":"康泰医学(300869)9月30日股东户数3.5万户,较上期减少1.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478158795","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478158795?lang=zh_cn&edition=full","pubTime":"2024-10-27 17:02","pubTimestamp":1730019750,"startTime":"0","endTime":"0","summary":"证券之星消息,近日康泰医学披露,截至2024年9月30日公司股东户数为3.5万户,较6月30日减少519.0户,减幅为1.46%。在医疗器械行业个股中,康泰医学股东户数高于行业平均水平,截至9月30日,医疗器械行业平均股东户数为2.02万户。从股价来看,2024年6月30日至2024年9月30日,康泰医学区间涨幅为27.01%,在此期间股东户数减少519.0户,减幅为1.46%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102700013230.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300869","BK0251"],"gpt_icon":0},{"id":"2478192130","title":"康泰医学(300869.SZ)发布前三季度业绩,净利润990.29万元,同比下降94.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478192130","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478192130?lang=zh_cn&edition=full","pubTime":"2024-10-27 16:50","pubTimestamp":1730019028,"startTime":"0","endTime":"0","summary":"智通财经APP讯,康泰医学(300869.SZ)发布2024年第三季度报告,公司前三季度营业收入3.34亿元,同比下降45.91%;归属于上市公司股东的净利润990.29万元,同比下降94.92%;归属于上市公司股东的扣除非经常性损益的净亏损645.69万元;基本每股收益0.0246元/股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1200699.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300869"],"gpt_icon":0},{"id":"2478315884","title":"图解康泰医学三季报:第三季度单季净利润同比减85.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478315884","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478315884?lang=zh_cn&edition=full","pubTime":"2024-10-27 16:47","pubTimestamp":1730018844,"startTime":"0","endTime":"0","summary":"证券之星消息,康泰医学2024年三季报显示,公司主营收入3.34亿元,同比下降45.91%;归母净利润990.29万元,同比下降94.92%;扣非净利润-645.69万元,同比下降103.53%;其中2024年第三季度,公司单季度主营收入1.22亿元,同比下降0.53%;单季度归母净利润173.58万元,同比下降85.81%;单季度扣非净利润-260.33万元,同比下降125.79%;负债率31.74%,投资收益1536.07万元,财务费用-368.11万元,毛利率49.9%。财报数据概要请见下图:以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102700012730.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300869"],"gpt_icon":0},{"id":"2477382342","title":"康泰医学最新公告:股东拟减持不超过1.7145%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477382342","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477382342?lang=zh_cn&edition=full","pubTime":"2024-10-22 19:00","pubTimestamp":1729594843,"startTime":"0","endTime":"0","summary":"康泰医学公告,持股5%以上股东王桂丽、董事兼高级管理人员杨志山、郑敏,监事高瑞斌,高级管理人员付春元、寇国治、许云龙、刘振红计划减持公司股份,减持比例合计不超过1.7145%。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102200030364.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300869","BK0251"],"gpt_icon":0},{"id":"2477538450","title":"康泰医学(300869.SZ)多位股东拟合计减持不超688.9万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2477538450","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477538450?lang=zh_cn&edition=full","pubTime":"2024-10-22 18:53","pubTimestamp":1729594431,"startTime":"0","endTime":"0","summary":"智通财经APP讯,康泰医学(300869.SZ)公告,公司股东王桂丽,董事兼高级管理人员杨志山、郑敏,监事高瑞斌,高级管理人员付春元、寇国治、许云龙、刘振红拟减持公司股份,合计拟减持不超688.9万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1197561.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0251","300869"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2020-08-24","address":"河北省秦皇岛市海港区经济技术开发区秦皇西大街112号","stockEarnings":[{"period":"1week","weight":-0.0634},{"period":"1month","weight":-0.0141},{"period":"3month","weight":0.2365},{"period":"6month","weight":0.131},{"period":"1year","weight":-0.2281},{"period":"ytd","weight":-0.24}],"companyName":"康泰医学系统(秦皇岛)股份有限公司","boardCode":"AI0035","perCapita":"7184股","boardName":"专用设备制造业","registeredCapital":"40180万元","compareEarnings":[{"period":"1week","weight":-0.0264},{"period":"1month","weight":0.0072},{"period":"3month","weight":0.2314},{"period":"6month","weight":0.124},{"period":"1year","weight":0.1612},{"period":"ytd","weight":0.1328}],"survey":" 康泰医学系统(秦皇岛)股份有限公司的主营业务是医疗诊断、监护设备的研发、生产和销售。产品涵盖血氧类、心电类、超声类、监护类、血压类等多个大类,建立了完善的研发、生产和销售体系。2023年4月,公司Remoltar远程专业彩色多普勒超声诊断系统荣获德国IF设计奖和意大利A设计奖。2023年10月,公司的儿童红外体温计产品斩获2023年广交会设计创新奖银奖,呼吸训练器、动态心电监护仪两款产品斩获铜奖。","serverTime":1734704874558,"listedPrice":10.16,"stockholders":"35014人(较上一季度减少1.46%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康泰医学(300869)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康泰医学(300869)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康泰医学,300869,康泰医学股票,康泰医学股票老虎,康泰医学股票老虎国际,康泰医学行情,康泰医学股票行情,康泰医学股价,康泰医学股市,康泰医学股票价格,康泰医学股票交易,康泰医学股票购买,康泰医学股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康泰医学(300869)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康泰医学(300869)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}